Drug intelligence / Profile preview

nicotinamide

Development stage
Phase 4
Modality
Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

Nicotinamide, also known as niacinamide or NAM, is a water-soluble form of vitamin B3 and an amide derivative of nicotinic acid. It is an essential nutrient found in food and used both as a dietary supplement and medication. As a supplement, it prevents and treats pellagra (niacin deficiency) without causing the skin flushing associated with niacin. Medically, it is used orally for deficiency states and topically for acne due to its anti-inflammatory properties; it also reduces the risk of non-melanoma skin cancers in high-risk individuals. Mechanistically, it serves as a precursor to NAD+ (nicotinamide adenine dinucleotide), playing critical roles in cellular metabolism, DNA repair (as part of coenzyme NAD/NADP), redox reactions, and cell signaling pathways including sirtuin regulation. At pharmacological doses, it can inhibit sirtuins and certain ADP-ribosyltransferases (e.g., PARPs). It has antioxidant effects and modulates immune responses by inhibiting pro-inflammatory cytokines such as interleukin 8 via toll-like receptor pathways[1][2][5]. Side effects are minimal at normal doses but may include liver toxicity at very high intakes.

Brand names
FortaplexInfuviteInfuvite PediatricMvc-fluorideMvi PediatricNatafortNeo-bexNicomidePregvitTandem Plus
Other names
niacinamidenicotinamidanicotinamidumnicotinic acid amidenicotinic amideβ-pyridinecarboxamide3-pyridinecarboxamide
02

Targets

PARP1 (Poly (adp-ribose) polymerase 1)SIRT (Sirtuin family)

Beyond the preview

Go deeper on nicotinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call